LINC01788: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01788

NCBI ID: G101927244

LINC01788

Other Name(s): long intergenic non-protein coding RNA 1788 | Long intergenic non-protein coding RNA 1788

LINC01788: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01788 is a long non-coding RNA (lncRNA) that has been identified in various studies as having potential drug targets and biomarker properties. This RNA has been shown to play a critical role in the regulation of cellular processes, including cell adhesion, migration, and invasion. As a result, LINC01788 has attractiveness as a potential drug target and biomarker.

Drug Target Potential

LINC01788 has been shown to be involved in several cellular processes that are crucial for the development and progression of cancer. For instance, LINC01788 has been shown to be involved in the regulation of cell adhesion, which is a critical process for the maintenance of tissue structure and function. Adhesion is also a critical process for the development of cancer stem cells, which are cancer-initiating cells that have the ability to give rise to a variety of different tumors.

In addition to its role in cell adhesion, LINC01788 has also been shown to be involved in the regulation of cell migration and invasion. These processes are critical for the development of cancer, as they allow cancer cells to migrate and invade surrounding tissues, which can lead to the formation of tumors.

Biomarker Potential

LINC01788 has also been shown to be involved in the regulation of several signaling pathways that are important for the development and progression of cancer. For instance, LINC01788 has been shown to be involved in the regulation of the NF-kappa pathway, which is a critical pathway for the development and progression of cancer.

In addition to its role in the NF-kappa pathway, LINC01788 has also been shown to be involved in the regulation of the PI3K/Akt pathway, which is another important pathway for the development and progression of cancer.

Conclusion

In conclusion, LINC01788 is a long non-coding RNA that has potential as a drug target and biomarker. Its involvement in the regulation of cell adhesion, migration, and invasion, as well as its involvement in several signaling pathways, make it an attractive target for drug development. Further research is needed to fully understand the potential of LINC01788 as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1788

The "LINC01788 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01788 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets